Results 191 to 200 of about 5,512 (205)
Some of the next articles are maybe not open access.

Monkeypox Virus (MPXV) Infection: A Review

Infectious Disorders - Drug Targets
Abstract: Monkeypox is a viral disease; its outbreak was recently declared a global emergency by the World Health Organization. For the first time, a monkeypox virus (MPXV)-infected patient was found in India. Various researchers back-to-back tried to find the solution to this health emergency just after COVID-19.
Rosy, Kumari   +4 more
openaire   +2 more sources

MPXV in silico analysis manuscript supplementary figures

2023
Supplementary figures and tables associated with the manuscript "An in silico analysis of PCR-based monkeypox virus detection assays: a case study for ongoing clinical surveillance"
openaire   +1 more source

Monkey Pox Virus (MPXV): Phylogenomics, Host-Pathogen Interactome, and Mutational Cascade

2022
AbstractWhile the world is still managing to recover from Covid-19 pandemic, Monkeypox awaits to bring in another global outbreak as a challenge to the entire mankind. However, Covid-19 pandemic have taught us lessons to move fast in viral genomic research to implement prevention and treatment strategies. One of the important aspects in Monkeypox virus
Roshan kumar   +11 more
openaire   +1 more source

Examining homology between MPXV and immunogenic VACV-derived peptides

Vaccine
The mpox virus (MPXV) came to global attention with the 2022 global outbreak. Current vaccination and post-exposure prophylaxis against MPXV consists of live vaccinia whole virus-based vaccines including ACAM2000®, JYNNEOS™, and LC16m8 originally developed against smallpox.
Lara I, Teodoro   +3 more
openaire   +2 more sources

MPXV Transmission at a Tattoo Parlor

New England Journal of Medicine, 2023
Myriam, Viedma-Martinez   +6 more
openaire   +2 more sources

Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo

New England Journal of Medicine
Tecovirimat is available for the treatment of mpox (formerly known as monkeypox) in Europe and the United States, on the basis of findings from efficacy studies in animals and safety evaluations in healthy humans. Evidence from randomized, controlled trials of safety and efficacy in patients with mpox is lacking.We conducted a double-blind, randomized,
Rosine, Ali   +55 more
openaire   +2 more sources

Tracing the footprints of MPXV in Asia: phylogenetic insights and lineage dynamics

Sexually Transmitted Infections
ObjectivesThe 2022 global outbreak of monkeypox virus (MPXV), previously confined to Central and West Africa, necessitates an enhanced understanding of its spread. Comprehensive genomic surveillance to understand the virus’s evolution and spread is needed, particularly in Asia.MethodsGenomic data from 169 MPXV genome sequences in Asia were analysed ...
Yung-Chun Chen   +4 more
openaire   +2 more sources

Ιός Mpox (MPXV): Νεότερα Δεδομένα στην Εργαστηρɩακή Δɩάγνωση

Η διπλωματική εργασία εξετάζει τον ιό Mpox (πρώην ευλογιά των πιθήκων), εστιάζοντας στη σημασία της έγκαιρης εργαστηριακής διάγνωσης. Αναλύονται σύγχρονες διαγνωστικές μέθοδοι, κυρίως η PCR, και συγκρίνονται με άλλες τεχνικές όπως η ορολογική διάγνωση και η ηλεκτρονική μικροσκοπία.
openaire   +1 more source

MPXV E MPOX: ANCORA UNA SFIDA ONE HEALTH?

The monkeypox virus (renamed MPXV), is a species of double-stranded DNA virus that causes Mpox disease in humans and other mammals. It is a zoonotic virus belonging to the Orthopoxvirus genus, making it closely related to the variola, cowpox, and vaccinia viruses.
openaire   +1 more source

TCM@MPXV: A Resource for Treating Monkeypox Patients in Traditional Chinese Medicine

Current Bioinformatics
Introduction: Traditional Chinese Medicine (TCM) has been extensively employed in the treatment of Monkeypox Virus (MPXV) infections, and it has historically played a significant role in combating diseases like contagious pox-like viral diseases in China.
Xin Zhang   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy